75FCMC22F0001↗
The Lewin Group, Inc. received this contract from Ofc of Acquisition and Grants Management, Centers for Medicare and Medicaid Services: $3.15M obligated so far for support- professional: other. It runs to 2029-08-24.
Key facts · data as of Oct 25, 2026
- Recipient
- The Lewin Group, Inc.
- Awarding agency
- Centers for Medicare and Medicaid Services (Department of Health and Human Services)
- Contracting office
- Ofc of Acquisition and Grants Management (75FCMC)
- Obligated to date
- $3.15M
- Potential value
- $24.47M
- Ends
- 2029-08-24
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75FCMC22F0001, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75FCMC22F0001_7530_75FCMC19D0096_7530
The Lewin Group, Inc.: all federal awards · Department of Health and Human Services: spending · Ofc of Acquisition and Grants Management: what it buys
EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL
What it is
- Product or service
- Support- Professional: Other (PSC R499)
- Industry
- Research and Development in the Social Sciences and Humanities (NAICS 541720)
- Contracting office
- Ofc of Acquisition and Grants Management (75FCMC)
- Competition
- Full and open competition · 4 offers received
- Pricing
- Cost plus fixed fee
- How it was bought
- Multiple-award IDIQ · under 75FCMC19D0096
- Where the work is
- Baltimore, MD · district MD-02
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
10 actions since 2022-12-19. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-03-23 | P00010 | Administrative change | $0 | DESIGN AND CARRY OUT AN INDEPENDENT EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL (ETC) AND THE KIDNEY CARE CHOICES MODEL (KCC) |
| 2026-02-13 | P00009 | Option exercised | $7.91M | DESIGN AND CARRY OUT AN INDEPENDENT EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL (ETC) AND THE KIDNEY CARE CHOICES MODEL (KCC) |
| 2026-01-30 | P00008 | Administrative change | $0 | DESIGN AND CARRY OUT AN INDEPENDENT EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL (ETC) AND THE KIDNEY CARE CHOICES MODEL (KCC) |
| 2025-06-16 | P00007 | Administrative change | -$4.76M | EOI::IMPLEMENTING THE PRESIDENT'S DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (FEB. 26, 2025)::EOI BILATERAL MODIFICATION TO DESCOPE TASK ORDER IN ACCORDANCE WITH EO 14222 |
| 2024-09-13 | P00006 | Administrative change | $0 | EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL |
| 2024-08-14 | P00005 | Administrative change | $0 | EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL |
| 2024-05-07 | P00004 | Administrative change | $0 | EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL |
| 2023-10-30 | P00003 | Administrative change | $0 | EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL |
| 2023-03-21 | P00002 | Supplemental agreement (work within scope) | $0 | EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL |
| 2022-12-19 | P00001 | Supplemental agreement (work within scope) | $0 | EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗